Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Etoricoxib

Etoricoxib

202409-33-4

DISCOVER
Etoricoxib D3

Etoricoxib D3

850896-71-8

DISCOVER
Ethopabate

Ethopabate

59-06-3

DISCOVER
Eplerenone

Eplerenone

107724-20-9

DISCOVER
Entecavir

Entecavir

142217-69-4

DISCOVER
Erythromycin-13C D3

Erythromycin-13C D3

959119-26-7

DISCOVER
(±)-Epinephrine-2,5,6,alpha,beta,beta D6

(±)-Epinephrine-2,5,6,alpha,beta,beta D6

1219803-77-6

DISCOVER
17beta-Estradiol-16,16,17 D3

17beta-Estradiol-16,16,17 D3

79037-37-9

DISCOVER
Enrofloxacin D5 HI (ethyl D5)

Enrofloxacin D5 HI (ethyl D5)

1219795-24-0

DISCOVER
Estrone-2,4,16,16 D4

Estrone-2,4,16,16 D4

53866-34-5

DISCOVER
Fenbuconazole

Fenbuconazole

114369-43-6

DISCOVER
Flumioxazine

Flumioxazine

103361-09-7

DISCOVER